| UniProt ID | S2546_HUMAN | |
|---|---|---|
| UniProt AC | Q96AG3 | |
| Protein Name | Solute carrier family 25 member 46 | |
| Gene Name | SLC25A46 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 418 | |
| Subcellular Localization |
Mitochondrion outer membrane Multi-pass membrane protein . |
|
| Protein Description | May play a role in mitochondrial dynamics by controlling mitochondrial membrane fission.. | |
| Protein Sequence | MHPRRPDGFDGLGYRGGARDEQGFGGAFPARSFSTGSDLGHWVTTPPDIPGSRNLHWGEKSPPYGVPTTSTPYEGPTEEPFSSGGGGSVQGQSSEQLNRFAGFGIGLASLFTENVLAHPCIVLRRQCQVNYHAQHYHLTPFTVINIMYSFNKTQGPRALWKGMGSTFIVQGVTLGAEGIISEFTPLPREVLHKWSPKQIGEHLLLKSLTYVVAMPFYSASLIETVQSEIIRDNTGILECVKEGIGRVIGMGVPHSKRLLPLLSLIFPTVLHGVLHYIISSVIQKFVLLILKRKTYNSHLAESTSPVQSMLDAYFPELIANFAASLCSDVILYPLETVLHRLHIQGTRTIIDNTDLGYEVLPINTQYEGMRDCINTIRQEEGVFGFYKGFGAVIIQYTLHAAVLQITKIIYSTLLQNNI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 14 | Phosphorylation | DGFDGLGYRGGARDE CCCCCCCCCCCCCCC | 15.89 | 28555341 | |
| 15 | Methylation | GFDGLGYRGGARDEQ CCCCCCCCCCCCCCC | 34.96 | 115917093 | |
| 32 | Phosphorylation | GGAFPARSFSTGSDL CCCCCCCCCCCCCCC | 26.17 | 23401153 | |
| 34 | Phosphorylation | AFPARSFSTGSDLGH CCCCCCCCCCCCCCC | 32.86 | 22167270 | |
| 35 | Phosphorylation | FPARSFSTGSDLGHW CCCCCCCCCCCCCCC | 38.40 | 30266825 | |
| 37 | Phosphorylation | ARSFSTGSDLGHWVT CCCCCCCCCCCCCCC | 29.74 | 30266825 | |
| 44 | Phosphorylation | SDLGHWVTTPPDIPG CCCCCCCCCCCCCCC | 28.52 | 30266825 | |
| 45 | Phosphorylation | DLGHWVTTPPDIPGS CCCCCCCCCCCCCCC | 24.17 | 25159151 | |
| 47 | Ubiquitination | GHWVTTPPDIPGSRN CCCCCCCCCCCCCCC | 50.50 | - | |
| 51 | Ubiquitination | TTPPDIPGSRNLHWG CCCCCCCCCCCCCCC | 39.30 | - | |
| 52 | Phosphorylation | TPPDIPGSRNLHWGE CCCCCCCCCCCCCCC | 16.79 | 30266825 | |
| 60 | Ubiquitination | RNLHWGEKSPPYGVP CCCCCCCCCCCCCCC | 65.41 | 21906983 | |
| 60 | Ubiquitination | RNLHWGEKSPPYGVP CCCCCCCCCCCCCCC | 65.41 | 21890473 | |
| 61 | Phosphorylation | NLHWGEKSPPYGVPT CCCCCCCCCCCCCCC | 27.14 | 28464451 | |
| 64 | Phosphorylation | WGEKSPPYGVPTTST CCCCCCCCCCCCCCC | 33.85 | 22199227 | |
| 68 | Phosphorylation | SPPYGVPTTSTPYEG CCCCCCCCCCCCCCC | 30.85 | 22199227 | |
| 69 | Phosphorylation | PPYGVPTTSTPYEGP CCCCCCCCCCCCCCC | 25.24 | 22199227 | |
| 70 | Phosphorylation | PYGVPTTSTPYEGPT CCCCCCCCCCCCCCC | 29.84 | 22199227 | |
| 71 | Phosphorylation | YGVPTTSTPYEGPTE CCCCCCCCCCCCCCC | 28.00 | 22199227 | |
| 73 | Phosphorylation | VPTTSTPYEGPTEEP CCCCCCCCCCCCCCC | 33.34 | 26434776 | |
| 77 | Phosphorylation | STPYEGPTEEPFSSG CCCCCCCCCCCCCCC | 64.93 | 28857561 | |
| 88 | Phosphorylation | FSSGGGGSVQGQSSE CCCCCCCCCCCCCHH | 17.97 | 27080861 | |
| 95 | Ubiquitination | SVQGQSSEQLNRFAG CCCCCCHHHHHHHCC | 65.42 | - | |
| 136 | Phosphorylation | VNYHAQHYHLTPFTV CCCCCCCCCCCCEEE | 6.09 | - | |
| 142 | Phosphorylation | HYHLTPFTVINIMYS CCCCCCEEEEEEEEE | 22.98 | 25332170 | |
| 148 | Phosphorylation | FTVINIMYSFNKTQG EEEEEEEEECCCCCC | 13.30 | - | |
| 149 | Phosphorylation | TVINIMYSFNKTQGP EEEEEEEECCCCCCC | 12.64 | - | |
| 193 | Ubiquitination | LPREVLHKWSPKQIG CCHHHHHCCCHHHHH | 45.25 | - | |
| 195 | Phosphorylation | REVLHKWSPKQIGEH HHHHHCCCHHHHHHH | 27.33 | 24719451 | |
| 197 | Ubiquitination | VLHKWSPKQIGEHLL HHHCCCHHHHHHHHH | 49.37 | 21890473 | |
| 197 | Ubiquitination | VLHKWSPKQIGEHLL HHHCCCHHHHHHHHH | 49.37 | 21890473 | |
| 197 | Ubiquitination | VLHKWSPKQIGEHLL HHHCCCHHHHHHHHH | 49.37 | 21890473 | |
| 210 | Phosphorylation | LLLKSLTYVVAMPFY HHHHHHHHHHHCCCC | 9.75 | - | |
| 241 | Ubiquitination | TGILECVKEGIGRVI CCHHHHHHHCCCCHH | 62.98 | - | |
| 364 | Phosphorylation | YEVLPINTQYEGMRD CEEECCCCCCCCHHH | 32.99 | 27307780 | |
| 366 | Phosphorylation | VLPINTQYEGMRDCI EECCCCCCCCHHHHH | 16.65 | 27307780 | |
| 375 | Phosphorylation | GMRDCINTIRQEEGV CHHHHHHHHHHHHCC | 9.53 | 27307780 | |
| 396 | Phosphorylation | FGAVIIQYTLHAAVL CCCHHHHHHHHHHHH | 10.81 | 29514088 | |
| 397 | Phosphorylation | GAVIIQYTLHAAVLQ CCHHHHHHHHHHHHH | 8.83 | 29514088 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of S2546_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S2546_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S2546_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SCFD1_HUMAN | SCFD1 | physical | 22939629 | |
| FUND1_HUMAN | FUNDC1 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-45, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-45, AND MASSSPECTROMETRY. | |